StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio total assets

Total assets on the balance sheet at the end of each period.

Mustang Bio's total assets was $15.61M at Jun 30, 2026. For fiscal 2025 it was $17.59M, up 89.0% from the year before. The highest annual figure on record is $125.17M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.59M+89.0%
FY2024Dec 31, 2024$9.31M-47.5%
FY2023Dec 31, 2023$17.74M-80.8%
FY2022Dec 31, 2022$92.42M-26.2%
FY2021Dec 31, 2021$125.17M+13.9%
FY2020Dec 31, 2020$109.90M+49.6%
FY2019Dec 31, 2019$73.45M+71.8%
FY2018Dec 31, 2018$42.75M-32.7%
FY2017Dec 31, 2017$63.49M+130.9%
FY2016Dec 31, 2016$27.50M–
FY2015Dec 31, 2015$0–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.61M+19.7%
Q1 FY2026Mar 31, 2026$16.58M+11.2%
Q4 FY2025Dec 31, 2025$17.59M+89.0%
Q3 FY2025Sep 30, 2025$19.36M+169.2%
Q2 FY2025Jun 30, 2025$13.05M+53.1%
Q1 FY2025Mar 31, 2025$14.91M+2.2%
Q4 FY2024Dec 31, 2024$9.31M-47.5%
Q3 FY2024Sep 30, 2024$7.19M-65.0%
Q2 FY2024Jun 30, 2024$8.52M-70.7%
Q1 FY2024Mar 31, 2024$14.59M-80.2%
Q4 FY2023Dec 31, 2023$17.74M-80.8%
Q3 FY2023Sep 30, 2023$20.57M-81.1%
Q2 FY2023Jun 30, 2023$29.09M-76.1%
Q1 FY2023Mar 31, 2023$73.61M-46.3%
Q4 FY2022Dec 31, 2022$92.42M-26.2%
Q3 FY2022Sep 30, 2022$108.84M-19.2%
Q2 FY2022Jun 30, 2022$121.91M-14.9%
Q1 FY2022Mar 31, 2022$136.96M-3.4%
Q4 FY2021Dec 31, 2021$125.17M+13.9%
Q3 FY2021Sep 30, 2021$134.71M+56.5%
Q2 FY2021Jun 30, 2021$143.21M+47.9%
Q1 FY2021Mar 31, 2021$141.82M+106.9%
Q4 FY2020Dec 31, 2020$109.90M+49.6%
Q3 FY2020Sep 30, 2020$86.07M+2.7%
Q2 FY2020Jun 30, 2020$96.83M+4.5%
Q1 FY2020Mar 31, 2020$68.56M+35.8%
Q4 FY2019Dec 31, 2019$73.45M+71.8%
Q3 FY2019Sep 30, 2019$83.84M+69.3%
Q2 FY2019Jun 30, 2019$92.63M+66.4%
Q1 FY2019Mar 31, 2019$50.49M-17.4%
Q4 FY2018Dec 31, 2018$42.75M-32.7%
Q3 FY2018Sep 30, 2018$49.51M-27.1%
Q2 FY2018Jun 30, 2018$55.68M-24.6%
Q1 FY2018Mar 31, 2018$61.09M-18.6%
Q4 FY2017Dec 31, 2017$63.49M+130.9%
Q3 FY2017Sep 30, 2017$67.89M+510.6%
Q2 FY2017Jun 30, 2017$73.84M–
Q1 FY2017Mar 31, 2017$75.03M–
Q4 FY2016Dec 31, 2016$27.50M–
Q3 FY2016Sep 30, 2016$11.12M–

More Mustang Bio figures

See a number that looks wrong?